Analysis of stroke risk factors of Han and Uyghur in Turpan area

LI Yongchang; ZHOU Lin; FU Ke; PENG Yi; HE Cai; YU Xiang

PDF(5692 KB)

Journal of Hunan Normal University(Medical Science) ›› 2023, Vol. 20 ›› Issue (6) : 79-86.

Clinical Medicine

Analysis of stroke risk factors of Han and Uyghur in Turpan area

LI Yongchang, ZHOU Lin, FU Ke, PENG Yi, HE Cai, YU Xiang

Author information +

History +

Abstract

Objective To statistically analyze the distribution characteristics of stroke risk factors in Han and Uygur populations in Turpan area. Methods From January 2021 to December 2021,people aged 40 and above（3269 Han and Uyghur people in total）in the Physical examination center database of Turpan People's Hospital were selected as the research objects. The statistical analysis data included general information,laboratory test results and past history. Result The prevalence of hypertension in Uyghur Chinese nationality aged 41-50 years is significantly lower than that in Hannationality,while the prevalence of hypertension in Uyghur nationality aged 71-80 is significantly higher than that in Han nationality. The smoking rate of Uyghur nationality aged 51-60 is significantly higher than that of Han nationality;The prevalence of diabetes among Uyghur nationality aged 71-80 is lower than that of Han nationality;The overweight rate of Uyghur men and women aged 41-80 was significantly higher than that of Han nationality group,while there were statistical differences in the 41-50 age groups and 51-60 age groups. The drinking rate of Uyghur nationality aged 61-70 and 71-80 is significantly lower than that of Han nationality. Conclusion There are differences in the distribution of stroke risk factors among Han and Uygur Chinese nationalityin Turpan area,and we need to monitor and intervene on stroke risk factors according to ethnicity,gender and other factors.

Key words

risk factors / stroke / Uyghur Chinese nationality / Hannationality

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LI Yongchang, ZHOU Lin, FU Ke, PENG Yi, HE Cai, YU Xiang. Analysis of stroke risk factors of Han and Uyghur in Turpan area[J]. Journal of Hunan Normal University(Medical Science). 2023, 20(6): 79-86

References

[1] CHEN Y,WRIGHT N,GUO Y,et al.Mortality and recurrent vascular events after first incident stroke:a 9-year community-based study of 0·5 million Chinese adults[J]. Lancet Glob Health,2020,8(4):e580-e590.
[2] O’DONNELL M J,XAVIER D,LIU L,et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries(the INTERSTROKE study):a case-control study[J]. Lancet,2010,376(9735):112-123.
[3] COLLINS R,REITH C,EMBERSON J,et al.Interpretation of the evidence for the efficacy and safety of statin therapy[J]. Lancet,2016,388(10059):2532-2561.
[4] XIE X,ATKINS E,LV J,et al.Effects of intensive blood pressure lowering on cardiovascular and renal outcomes:updated systematic review and meta-analysis[J]. Lancet,2016,387(10017):435-443.
[5] PETERS S A E,HUXLEY R R,WOODWARD M. Diabetes as a risk factor for stroke in women compared with men:a systematic review and meta-analysis of 64 cohorts,including 775 385 individuals and 12 539 strokes[J]. Lancet,2014,383(9933):1973-1980.
[6] ZHANG C,QIN Y-Y,CHEN Q,et al.Alcohol intake and risk of stroke:A dose–response meta-analysis of prospective studies[J]. Int J Cardiol,2014,174(3):669-677.
[7] MONS U,MÜEZZINLER A,GELLERT C,et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults:meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium[J]. Bmj,2015,350:h1551.
[8] NATH M,SWARNKAR P,SHARMA R,et al.Association of modifiable risk factors with ischaemic stroke subtypes in Asian versus Caucasian populations:A systematic review and meta-analysis[J]. Eur J Clin Invest,2022,52(11):e13849.
[9] BOEHME A K,ESENWA C,ELKIND M S. Stroke Risk Factors,Genetics,and Prevention[J]. Circ Res,2017,120(3):472-495.
[10] LAW M R,MORRIS J K,WALD N J.Use of blood pressure lowering drugs in the prevention of cardiovascular disease:meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies[J]. Bmj,2009,338:b1665.
[11] NG M,FLEMING T,ROBINSON M,et al.Global,regional,and national prevalence of overweight and obesity in children and adults during 1980-2013:a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet,2014,384(9945):766-781.
[12] FLEGAL K M,CARROLL M D,OGDEN C L,et al.Prevalence and trends in obesity among US adults,1999-2008[J]. JAMA,2010,303(3):235-241.
[13] NING X,ZHAN C,YANG Y,et al.Secular trends in prevalence of overweight and obesity among adults in rural Tianjin,China from 1991 to 2011:a population-based study[J]. PLoS One,2014,9(12):e116019.
[14] FENG T,VEGARD M,STRAND L B,et al.Metabolically Healthy Obesity and Risk for Atrial Fibrillation:The HUNT Study[J]. Obesity(Silver Spring),2019,27(2):332-338.
[15] ECKEL N,LI Y,KUXHAUS O,et al.Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women(the Nurses’ Health Study):30 year follow-up from a prospective cohort study[J]. Lancet Diabetes Endocrinol,2018,6(9):714-724.
[16] O’DONNELL M J,CHIN S L,RANGARAJAN S,et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries(INTERSTROKE):a case-control study[J]. Lancet,2016,388(10046):761-775.
[17] CAVENDER M A,SCIRICA B M,RAZ I,et al. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c[J]. Am J Med,2016,129(3):340. e341-348.
[18] MAIDA C D,DAIDONE M,PACINELLA G,et al.Diabetes and Ischemic Stroke:An Old and New Relationship an Overview of the Close Interaction between These Diseases[J]. Int J Mol Sci,2022,23(4).
[19] FEIGIN V L,ROTH G A,NAGHAVI M,et al.Global burden of stroke and risk factors in 188 countries,during 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet Neurol,2016,15(9):913-924.
[20] MARKIDAN J,COLE J W,CRONIN C A,et al.Smoking and Risk of Ischemic Stroke in Young Men[J]. Stroke,2018,49(5):1276-1278.
[21] THRIFT A G,THAYABARANATHAN T,HOWARD G,et al.Global stroke statistics[J]. Int J Stroke,2017,12(1):13-32.
[22] KWAN J,HORSFIELD G,BRYANT T,et al.IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke[J]. Exp Gerontol,2013,48(9):960-965.
[23] DI RAIMONDO D,TUTTOLOMONDO A,BUTTÀ C,et al.Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation[J]. Curr Pharm Des,2012,18(28):4385-4413.
[24] CHEN J,LI S,ZHENG K,et al.Impact of Smoking Status on Stroke Recurrence[J]. J Am Heart Assoc,2019,8(8):e011696.
[25] GRISWOLD M G,FULLMAN N,HAWLEY C,et al.Alcohol use and burden for 195 countries and territories,1990–2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. The Lancet,2018,392(10152):1015-1035.
[26] JEONG S M,LEE H R,HAN K,et al.Association of Change in Alcohol Consumption With Risk of Ischemic Stroke[J]. Stroke,2022,53(8):2488-2496.
[27] 张艳炜,张倩,李山山,等. 中国新疆地区维吾尔族人群缺血性卒中的危险因素[J]. 国际脑血管病杂志,2016,24(1):13-16.
[28] 蔡坚,张小宁,吐尔逊·沙比尔,等. 缺血性卒中危险因素的种族差异—— 中国新疆汉族与维吾尔族患者的回顾性比较[J]. 国际脑血管病杂志,2011,19(12):887-889.